BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5589304)

  • 1. [Triggering of massive thrombus formation with epsilon-aminocaproic acid after previous activation of the coagulation system].
    Herschlein HJ; Steichele DF
    Thromb Diath Haemorrh; 1967 May; 17(3-4):568-77. PubMed ID: 5589304
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombus weight as a measure of hypercoagulability induced by drugs.
    MacIomhair M; Lavelle SM
    Thromb Haemost; 1979 Oct; 42(3):1018-21. PubMed ID: 505392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact product in experimental intravascular activation of the clotting system.
    Altman R; Rouvier J; Daldin J
    Rev Bras Pesqui Med Biol; 1973; 6(5):223-8. PubMed ID: 4774622
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of epsilon aminocaproic acid (EACA) and Trasylol on thromboplastin-induced intravascular coagulation, studied in dogs with iodine-labelled fibrinogen.
    Nordstrm S; Zetterqvist E
    Acta Physiol Scand; 1969; 76(1):93-105. PubMed ID: 5307271
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of epsilon-aminocaproic acid as an anti-allergic agent and its effect on blood coagulation system].
    Zatikian LO
    Zh Eksp Klin Med; 1973; 13(3):16-9. PubMed ID: 4791710
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the anticoagulant effect of some inhibitors of fibrinolysis].
    Donner L; Housková J
    Sb Lek; 1969 Apr; 71(4):85-91. PubMed ID: 5305357
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electron microscope studies of thrombocytes of rabbits before and after administration of epsilon-aminocaproic acid].
    Beznosikova VK; Chaplygina ZA; Beznosikov BO
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):32-7. PubMed ID: 5736821
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the aspects of the hemostatic action of epsilon-aminocaproic acid].
    Barkagan ZS; Bur'ianov IaB; Kompaneets EIu; Lapa VA; Eremin GF; Mitel'man LSh; Shevchenko VI; Shlotgauér NR
    Probl Gematol Pereliv Krovi; 1965 Aug; 10(8):20-6. PubMed ID: 5868998
    [No Abstract]   [Full Text] [Related]  

  • 9. Epsilon aminocaproic acid--a dangerous weapon.
    Ratnoff OD
    N Engl J Med; 1969 May; 280(20):1124-5. PubMed ID: 5813521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of hemostatic effect of epsilon-aminocaproic acid].
    Kaznacheev VP; Dzizinskiĭ AA
    Probl Gematol Pereliv Krovi; 1968 Dec; 13(12):36-9. PubMed ID: 5736927
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of Yoshida sarcoma, -aminocaproic acid and sintrom on the blood clotting system in rats.
    Kotschy M; Grzebieluch M; Szacki J; Lawiñski M
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):515-22. PubMed ID: 5095070
    [No Abstract]   [Full Text] [Related]  

  • 12. [Animal experimental studies of the effect of synthetic antifibrinolytics].
    Markwardt F; Klöcking HP
    Acta Biol Med Ger; 1966; 17(6):746-54. PubMed ID: 5990894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of tsalol and epsilon-aminocaproic acid in preserving blood].
    Katsadze IuL; Shulutko LS
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):52-3. PubMed ID: 4543610
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies on the mechanism of microthrombosis formation].
    Hara H
    Igaku Kenkyu; 1967 Jun; 37(3):333-50. PubMed ID: 4230138
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative effectiveness of epsilon-aminocaproic acid and contrical in preventing complement activation on immune complexes].
    Tsibul'kin AP; Raĭzman SM
    Farmakol Toksikol; 1981; 44(3):316-9. PubMed ID: 6169545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of aspirin and epsilon-aminocaproic acid on the duration of hemorrhage].
    Baranov AE; Kapustianova OI
    Probl Gematol Pereliv Krovi; 1972 Oct; 17(10):43-5. PubMed ID: 4668401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombelastographic evaluation of blood coagulation in acute myocardial infarct treated with 3,4,5 trimethoxybenzoylaminocaproate sodium].
    Zangara A; Dugoni D; Anselmi L
    Minerva Med; 1973 Mar; 64(16):803-11. PubMed ID: 4723563
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. A study in experimental animals and in clinical material.
    Becker J; Borgström S
    Acta Chir Scand; 1968; 134(5):343-9. PubMed ID: 5731268
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study of the respective effects of acetylsalicylic acid, hydrocortisone and epsilon-aminocaproic acid on the bleeding time].
    d' Auteuil P; Gauthier Y; Sirois M; Martin SC
    Union Med Can; 1968 Sep; 97(9):1177-81. PubMed ID: 4921608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.